文献速递其他结缔组织病

特发性炎症性肌病患者的乳糜泻样小肠活检表现:现有文献综述

Small intestinal biopsy findings consistent with celiac disease in patients with idiopathic inflammatory myopathy: Review of existing literature.
PubMed 文献 · Semin Arthritis Rheum · 2021-07-25

本系统综述检索了1976至2017年发表的30例特发性炎症性肌病(IIM)合并小肠活检符合乳糜泻(CeD)的病例。部分患者无胃肠道症状或传统CeD血清学阴性,24例报告无麸质饮食(GFD)效果者中14例(58%)IIM改善,7例(29%)仅用GFD即维持临床缓解。

要点

  • IIM患者的小肠活检可符合CeD,即使无典型胃肠道症状或传统血清学阴性。
  • 报告GFD效果的24例中14例(58%)IIM改善,7例(29%)仅用GFD维持临床缓解。
  • 对IIM患者需警惕合并CeD,但GFD对肠道外器官的效果尚需更多研究。

核心结论

  • IIM病例中小肠活检符合CeD可无典型症状或传统血清学阳性,多数病例在引入GFD后IIM改善。

研究设计与样本

  • 系统检索MEDLINE、PubMed和EMBASE并补充参考文献筛选及Google/Google Scholar非系统检索,纳入1975年后发表的IIM合并小肠活检符合CeD的病例报告。

主要发现

  • 共纳入1976至2017年发表的30例病例。
  • 19例有CeD诊断前胃肠道症状信息,其中6/19(32%)无胃肠道症状。
  • 23/30例有CeD相关血清学数据:肌内膜抗体阳性10/18(56%),组织转谷氨酰胺酶抗体阳性2/9(22%),天然麦胶蛋白抗体阳性16/18(89%)。
  • 24例报告了GFD对IIM的临床效果,14/24(58%)有改善迹象,包括3例其他治疗抵抗的包涵体肌炎。
  • 纵向随访显示7/24(29%)以GFD为唯一治疗干预维持临床IIM缓解。

关键数值与推荐

  • 肌内膜抗体阳性10/18(56%),组织转谷氨酰胺酶抗体阳性2/9(22%),天然麦胶蛋白抗体阳性16/18(89%)。
  • GFD后IIM改善14/24(58%),仅用GFD维持临床缓解7/24(29%)。

临床怎么用

  • 对IIM患者应警惕合并CeD,即使无典型胃肠道症状或传统血清学阴性。
  • 小肠活检符合CeD的IIM患者可考虑GFD,但需更多研究明确其对肠道外器官的效果。

局限性

  • 本文为病例报告的系统综述,病例数有限,部分数据缺失,GFD效果为描述性报告,缺乏对照研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Case reports have described patients with idiopathic inflammatory myopathies (IIM) and a concurrent diagnosis of celiac disease (CeD) for whom the muscle inflammation (myositis) component of IIM improves after the patients start standard treatment with gluten-free diet (GFD). A connection between IIM and CeD is not commonly recognized. AIM: In this first systematic review of the topic, we aimed to explore all peer-reviewed publications of IIM cases and concomitant small intestinal biopsy findings consistent with CeD, published after 1975. METHODS: Systematic literature searches were performed in MEDLINE, PubMed, and EMBASE, supplemented by screening of references and non-systematic searches via Google and Google Scholar. RESULTS: Altogether 30 cases published between 1976 and 2017 were uncovered. Information about gastrointestinal symptoms prior to CeD diagnosis was available for 19 patients, with 6/19 (32%) reporting no GI symptoms. CeD-related serological data were available in 23/30 patients. Endomysial antibodies were present in 10/18 (56%), while only 2/9 (22%) had antibodies against tissue transglutaminase. Serum antibodies to native gliadin were present in 16/18 (89%). Clinical effects of a GFD on the IIM were reported for 24 patients, with signs of improvement in 14/24 (58%), including three patients with otherwise therapy-resistant inclusion body myositis. Longitudinal follow-up data available from the published studies indicated that 7/24 (29%) remained in clinical IIM remission with GFD as the sole therapeutic intervention. CONCLUSION: In the IIM cases presented here, duodenal biopsy findings consistent with celiac disease was sometimes present without classical CeD symptoms or positive traditional CeD serology, and in the majority of cases, the IIM improved after introduction of a gluten-free diet. While extra vigilance towards CeD in IIM patients seems warranted, there is need for more research to clarify if GFD has effects on organ systems other than the small intestine in patients with IIM and small intestinal biopsy findings consistent with CeD.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Nyborg GA, Molberg Ø. Small intestinal biopsy findings consistent with celiac disease in patients with idiopathic inflammatory myopathy: Review of existing literature. Semin Arthritis Rheum. 2021. PMID: 34416625. doi:10.1016/j.semarthrit.2021.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。